Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 91-100 of 856

NICE consults again on non-Hodgkin's lymphoma treatment
NICE has launched a second consultation on draft guidance for a drug to treat an aggressive form of lymphoma, which is a cancer that develops in the body's immune system.
October 15, 2013

NICE final draft guidance recommends drugs to treat chronic hepatitis C in children and young people
In final draft guidance NICE has confirmed its earlier draft guidance recommending peginterferon alfa in combination with ribavirin as an option for treating chronic hepatitis C in children and young people.
October 11, 2013

NICE draft guidance recommends tests to help target treatments for bowel cancer
In draft guidance published today NICE has recommended a number of tests to help doctors target treatments more effectively for people with advanced (metastatic) colorectal cancer
October 3, 2013

NICE says yes to treatment for rare autoimmune disease in draft guidance
NICE has today (3 October) published draft guidance recommending rituximab (MabThera, Roche Products) as an option for treating some adults with the rare autoimmune condition, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
October 3, 2013

NICE recommends tests to help diagnose serious bowel conditions
New guidance NICE advises doctors to use simple stool tests as an option to distinguish between potentially serious inflammatory bowel disease (IBD) and less serious irritable bowel syndrome (IBS). The faecal calprotectin test is used in people with recent lower gastrointestinal symptoms that could be due to either type of disorder and in whom assessment by a specialist is being considered.
October 2, 2013

NICE proposes green light to treatment for common eye problem in people with diabetes in final draft guidance
In final draft guidance published by NICE, fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences) is recommended as an option for the treatment of chronic diabetic macular oedema considered insufficiently responsive to available therapies.
October 1, 2013

Care and support of children and young people with depression needs to be improved, says NICE in new standards
The National Institute for Health and Care Excellence (NICE) has issued standards to improve the care and support of children and young people with depression.
September 30, 2013

NICE publishes draft guidance on suite of ovarian cancer drugs
The National Institute for Health and Care Excellence (NICE) is currently considering if five ovarian cancer treatments work well enough to be funded by the NHS.
September 27, 2013

Providing shelter for homeless people with tuberculosis: just one way local government can help tackle TB, says NICE
Effective ways to help local authorities tackle tuberculosis (TB) in vulnerable groups are set out in a new Local Government Public Health Briefing published by NICE today.
September 25, 2013

New NICE briefing to help local authorities improve people's health while also saving money
How councils can benefit from the win-win situation of improving people?s health whilst also saving money is the subject of a new public health briefing from NICE, published today.
September 25, 2013

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.